Lymph node hemophagocytosis in rickettsial diseases: a pathogenetic role for CD8 T lymphocytes in human monocytic ehrlichiosis (HME)? by Dierberg, Kerry L & Dumler, J Stephen
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Infectious Diseases
Open Access Research article
Lymph node hemophagocytosis in rickettsial diseases: a 
pathogenetic role for CD8 T lymphocytes in human monocytic 
ehrlichiosis (HME)?
Kerry L Dierberg and J Stephen Dumler*
Address: Division of Medical Microbiology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 
USA
Email: Kerry L Dierberg - kdierbe1@jhmi.edu; J Stephen Dumler* - sdumler@jhmi.edu
* Corresponding author    
Abstract
Background: Human monocytic ehrlichiosis (HME) and Rocky Mountain spotted fever (RMSF)
are caused by Ehrlichia chaffeensis and Rickettsia rickettsii, respectively. The pathogenesis of RMSF
relates to rickettsia-mediated vascular injury, but it is unclear in HME.
Methods: To study histopathologic responses in the lymphatic system for correlates of immune
injury, lymph nodes from patients with HME (n = 6) and RMSF (n = 5) were examined. H&E-stained
lymph node tissues were examined for five histopathologic features, including hemophagocytosis,
cellularity, necrosis, and vascular congestion and edema. The relative proportions of CD68
macrophages, CD8 and CD4 T lymphocytes, and CD20 B lymphocytes were evaluated by
immunohistochemical staining.
Results: Hemophagocytosis was similar in HME and RMSF, and was greater than in control cases
(p = .015). Cellularity in HME was not different from controls, whereas RMSF lymph nodes were
markedly less cellular (p < 0.002). E. chaffeensis-infected mononuclear phagocytes were infrequent
compared to R. rickettsii-infected endothelial cells. More CD8 cells in lymph nodes were observed
with HME (p < .001), but no quantitative differences in CD4 lymphocytes, macrophages, or B
lymphocytes were identified.
Conclusion: Hemophagocytosis, CD8 T cell expansion, and the paucity of infected cells in HME,
suggest that E. chaffeensis infection leads to macrophage activation and immune-mediated injury.
Background
The tick-borne obligate intracellular bacteria Ehrlichia
chaffeensis and Rickettsia rickettsii are the causes of human
monocytic ehrlichiosis (HME) and Rocky Mountain spot-
ted fever (RMSF) diseases, respectively [1]. E. chaffeensis is
transmitted by the Lone Star tick, Amblyomma americanum,
and human infection typically presents with fever, myal-
gias, pancytopenia, and mild to moderate elevation of
serum transaminases [2]. This clinical presentation is eas-
ily confused with that of RMSF, which typically presents
with fever, rash, and headache. R. rickettsii is known to
infect endothelial cells, leading to direct rickettsia-medi-
ated vascular injury accompanied by a vigorous but pro-
tective Th1 immune response [3]. E. chaffeensis is known
to infect cells in the monocyte/macrophage lineage, but
the pathogenesis of HME is less clear [4]. Lymphohistio-
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cytic-rich infiltrates, foamy macrophage infiltrates, and
non-caseating granulomas suggest diffuse activation of
the mononuclear phagocyte system and a role for host
inflammation and immunity in its pathogenesis [5,6]. In
this study, we examined documented cases of HME and
RMSF in order to quantitate and further delineate the
pathology and underlying pathogenesis of E. chaffeensis
infection.
Methods
Patients and tissue samples
H&E-stained and unstained slides or formalin-fixed paraf-
fin-embedded lymph node tissue blocks were obtained
for 6 cases of HME (5 autopsies and 1 biopsy) and 5 rep-
resentative cases of RMSF autopsies. All cases were docu-
mented by serologic studies (HME 3 cases; RMSF 1 case),
PCR amplification from peripheral blood (HME 2 cases;
RMSF 0 cases), or immunohistochemical demonstration
of either R. rickettsii or E. chaffeensis (HME 6 cases; RMSF
5 cases). The patients ranged in age from 6 to 80 years. In
addition, lymph node tissue from 8 control cases were
examined, including 4 infection controls (1 case each of
murine typhus [autopsy], cat scratch disease [biopsy],
tuberculosis [biopsy], and gram-positive coccus lymphad-
enitis [biopsy]) chosen to reflect a spectrum of potential
Th1 and Th2 immune induction, and 4 consecutive, ran-
dom autopsy cases from the Johns Hopkins Hospital for
which lymph node tissues were available at the time of
study inception (random controls, including 1 patient
with pulmonary embolism/cardiomyopathy, 1 patient
with congestive heart failure and chronic obstructive pul-
monary disease, 1 patient with a subarachnoid hemor-
rhage and 1 patient with myasthenia gravis and
bronchopneumonia). Control cases were selected to rep-
resent a broad, but not comprehensive spectrum of poten-
tial changes observed with other infections and non-
infectious processes. The lymph node specimens taken
during autopsy represent hilar and/or mediastinal lymph
nodes, and for biopsies, cervical or inguinal lymph nodes
were sampled. Generally one or two lymph nodes per
patient were evaluated and an entire 5 μm tissue section
for each lymph node was reviewed for relevant his-
topathologic features. No lymph nodes draining skin
lesions or other obvious inflammatory foci were used.
Approval for study of the tissues was obtained from The
Johns Hopkins Medicine Institutional Review Board.
Histologic and immunohistologic staining
H&E-stained lymph node tissues were examined for five
histopathologic features, including hemophagocytosis
(macrophage activation), cellularity (inflammatory cell
infiltration), necrosis (tissue damage), and vascular con-
gestion (non-cellular tissue inflammation) and edema
(vascular permeability). The relative proportions of CD68
macrophages (clone KP-1), CD8 (clone 1A5) and CD4 T
lymphocytes (clone 1F6), and CD20 B lymphocytes
(clone L26) were determined by immunohistochemical
staining of paraffin-embedded tissues from 5 of 6 HME
cases, 1 case of each of murine typhus and cat scratch dis-
ease, and 2 autopsy controls for which additional slides or
tissue were available. No unstained slides or formalin-
fixed paraffin-embedded lymph node tissue blocks were
available for 4 of the 5 RMSF cases, prompting exclusion
of RMSF from evaluation for immunophenotypic mark-
ers. All immunophenotyping antibodies were obtained
from Ventana Medical Systems, Inc., (Tucson, AZ) and a
modified avidin-biotin complex method was used after
pretreatment of slides in citrate buffer. Specificity of each
antibody reaction was confirmed prior to use consistent
with the Quality Control recommendations of the College
of American Pathologists Laboratory Accreditation Pro-
gram, Anatomic Pathology Checklist, or the NCCLS
Approved Guideline, and were confirmed with each run
by using normal lymph node or tonsil tissues with
defined distributions of the cell subsets studied.
Owing to the potential that semiquantitative assessment
may not produce normally distributed results, we elected
to use non-parametric studies to compare HME, RMSF,
and control groups. This involved blinding the slides as to
diagnosis and ranking the 19 cases for each histologic fea-
ture and the 9 cases for each immunophenotypic feature,
respectively [7-10]. Cases were evaluated for quantity, dis-
tribution, and severity of each feature by slide-to-slide
comparisons, until each case was assigned a rank number
that corresponded to rank position for each feature. Rank-
ing was conducted simultaneously by 2 microscopists to
assure consensus. These ranks were evaluated for each fea-
ture using one-tailed Mann-Whitney U-statistic nonpara-
metric tests where p values <.05 were considered
significant. For each comparison of two groups (HME vs.
controls, HME vs. RMSF, RMSF vs. controls), all features
were re-ranked for appropriate application of Mann-Whit-
ney U-statistical tests.
Immunohistologic demonstration of E. chaffeensis and R.
rickettsii was performed using biotinylated human anti-E.
chaffeensis for direct detection [6], E. chaffeensis mono-
clonal antibody 1A9 [11], or polyclonal rabbit anti-R. rick-
ettsii  [12] and appropriate biotinylated antibodies,
followed by detection using either streptavidin-alkaline
phosphatase (Dako) and naphthol phosphate/fast red/
levamisole substrate solution or streptavidin-horseradish
peroxidase and diaminobenzidine substrate. Extensive
washing with phosphate-buffered saline was performed
after each incubation. All specimens were counterstained
with Mayer's hematoxylin, mounted with Crystal Mount
(Biomeda, Hayward CA) and dried before applying cover-
slips. All immunohistologic preparations were examined
at a magnification of 400× for identification of infectedBMC Infectious Diseases 2006, 6:121 http://www.biomedcentral.com/1471-2334/6/121
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cells.  E. chaffeensis morulae and individual R. rickettsii
were identified by substrate reaction product, and
assessed for bacterial load by a semiquantitative method
ranging from none detected, graded as 0, and 1, 2, or 3 if
infected cells were found in <10%, 10 to 25%, and >25%
of microscopic fields, respectively.
Results
A summary of the median histopathologic rankings for
HME, RMSF, and control cases for each of the five features
is shown in Table 1. The main similarity between HME
and RMSF was the degree of hemophagocytosis (Figure
1), with median ranks of 15 and 13 for HME and RMSF,
respectively. These were significantly different from the
control cases (median 3.5, p = .015 vs. HME and p = .033
vs. RMSF). CD68 macrophages were less abundant in
HME than in controls. However, CD68 cells were gener-
ally detected as clusters in the lymph node medulla and
paracortical regions. This feature was present to a lesser
degree in one case each of RMSF, murine typhus, and cat
scratch disease, but not in a lymph node from a patient
with bronchopneumonia or with subarachnoid hemor-
rhage.
A difference between HME (median rank 11.5) and RMSF
(median rank 4) was the lower degree of cellularity found
in lymph nodes of RMSF patients (Figure 2), although this
difference was not significant (p = .063). In addition,
lymph nodes from RMSF patients were markedly less cel-
lular than those from controls (median rank 13.5; p =
.002). Lymph nodes from patients with HME had similar
degrees of cellularity as those of the infection controls (p
= .245). Although variable among patients with HME,
when cellularity was high, the histopathologic pattern
showed proliferation of lymphocytes both in and around
cortical follicles and more dominantly in the paracortical
T lymphocyte regions. This pattern was also observed for
the cat scratch disease control patient, whereas increased
cellularity with tuberculosis included an expansion of all
compartments and the additional presence of caseating
and non-caseating granulomas. Overall, the lymph node
histopathology in RMSF was not so much hypocellular,
except as compared with the increased cellularity
observed after immune stimulation with other infections,
including HME. Although no differences in the degree of
necrosis and congestion/edema were detected among
HME or RMSF cases and controls, as anticipated, the type
and pattern of necrosis were different, ranging from
numerous apoptotic cells in HME and cat scratch disease,
to vasculitis in RMSF and caseous necrosis in TB. Immu-
nophenotypic evaluation of the cells in lymph nodes (Fig-
ure 3) showed no significant difference between HME
cases and controls for CD68, CD4, and CD20 staining.
However, HME cases demonstrated significantly more
staining for CD8 than the other cases (p < .008), and these
cells comprised a substantial proportion of the increased
cellularity observed in the hypercellular paracortical
regions of lymph nodes.
Immunohistochemistry demonstrated rare to infrequent
infected cells in HME compared to a significantly greater
bacterial load for RMSF (mean semiquantitative grade 1.3
vs. 3.0, p = .003). R. rickettsii was identified at least focally
in each lymph node examined from RMSF patients,
whereas E. chaffeensis was identified only in 4 of 6 lymph
nodes from HME patients. The quantity of infected cells
and bacteria typical for each infection is demonstrated in
Figure 4.
Table 1: Median (range) of histopathologic and immunohistologic rankings of features among patients with HME, RMSF, or controls. 
High ranks correspond to a greater degree for each histologic or immunohistologic feature.
Histologic 
Feature n = 19
HME n = 6 RMSF n = 5 P HME vs. RMSF Controls n = 8 P HME vs. controls P RMSF vs. controls
Cellularity 11.5 (1–17) 4 (2–8) .063 13.5 (7–19) .245 .002
Phagocytic activity 15 (3.5–19) 13 (3.5–17) .268 3.5 (3.5–12) .015 .033
Necrosis 10.75 (2.5–18) 10.5 (2.5–13) .396 10.5 (3–19) .377 .584
Congestion/edema 11.5 (2–19) 8 (2–18) .396 11.5 (2–17) .638 .262
Bacterial load* 1.3 3.0 .003 1.5 .447 .025
Immunohistologi
c feature
HME [n] Controls [n]*** P HME vs. controls
CD68 [n = 9] 7 [5] (1–10) 3.5 [4] (2–8) .143
CD4 [n = 8**] 5 [4**] (3–9) 6 [4] (2–8) 1.000
CD8 [n = 9] 8 [5] (6–10) 2.5 [4] (1–5) .008
CD20 [n = 7**] 6 [3**] (3–8) 3.5 [4] (1–7) .288
* means and Student's t-tests for semiquantitative measurement of bacterial load
** immunostaining for CD4 and CD20 was unsatisfactory for 1 and 2 HME patients, respectively.
*** includes 1 case each of murine typhus, cat scratch disease, bronchopneumonia, and subarachnoid hemorrhageBMC Infectious Diseases 2006, 6:121 http://www.biomedcentral.com/1471-2334/6/121
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Discussion
Immune-mediated control of facultative and obligate
intracellular bacterial infection is particularly problematic
due to the sequestered location and the lack of immune
effector access to the pathogens. Thus, although many of
these infections are thought to cause tissue damage by
direct bacteria-mediated cell injury, an open question is to
what degree host inflammation and immunity contribute
to overall disease pathogenesis. Although much study of
the histopathology of both HME and RMSF has been con-
ducted, little correlation of these findings with potential
pathogenetic mechanisms has been attempted; for exam-
ple, the occurrence of hemophagocytosis in both entities
is well described [5,13-15], but the potential importance
of this feature in immunopathologic reactions is not well
addressed. Tissue injury seen in RMSF is most likely a
combination of direct rickettsia-mediated endothelial cell
injury, manifested by vasculitis and increased vascular
permeability [16,17], as well as by immune-mediated
injury, demonstrated here by hemophagocytosis. Animal
studies have shown that in balance, the potentially detri-
mental effects of Th1 immunity, local macrophage activa-
tion, and generation of cytotoxicity associated with CD8
or NK cells in rickettsial infection are beneficial to the
host, owing to effective pathogen control [16,18]. IFNγ,
TNFα, and other pro-inflammatory mediators produced
by these cells when responding to obligate intracellular
infections are known to activate macrophages, which
inhibit growth of both R. rickettsii and E. chaffeensis. How-
ever, this process could also cause bystander tissue injury
as suggested by the detection of hemophagocytosis
[17,19]. Given the differences in bacterial load between
RMSF and HME, tissue damage in HME is more likely a
result of poorly controlled macrophage activation and
release of effector molecules, including nitric oxide and
reactive oxygen species [3,17,20].
The excessive cytokine production induced with E. chaf-
feensis infection is believed to contribute to the toxic and
septic shock-like presentation seen in many cases of HME
[21]. As demonstrated in this study, hemophagocytosis
and evidence of inflammation-mediated tissue injury is
observed in HME and RMSF to an extent greater than that
in the selected infectious and non-infectious control
cases. In addition, HME cases demonstrated significantly
more infiltration by CD8 T lymphocytes than the control
cases. This further indicates that CD8 cells and possibly
cellular cytotoxicity likely play a significant role in HME
pathogenesis. Whether a similar role for CD8 cells exists
for RMSF, as suggested by studies in animal models, could
not be adequately assessed here and needs further investi-
gation.
Unlike the situation for the vasculotropic rickettsioses,
evidence for direct ehrlichia-mediated cell injury in vivo
has not been found, but the frequent presence of hemo-
phagocytosis implicates inflammatory- and immune-
mediated injury as possible major contributors. E. chaf-
feensis can cause cytolytic death of infected cells in vitro,
but this is unlikely to be responsible for the degree of leu-
kopenia, neutropenia and/or thrombocytopenia observed
in patients with HME given the low frequency of infected
cells in vivo as well as the lack of competent infection in
platelets, neutrophils, and megakaryocytes. The relative
lack of infected cells in HME compared to RMSF, despite
similar degrees of hemophagocytosis, and the marked
CD8 T cell expansion that could drive such responses, sug-
gests that Ehrlichia chaffeensis infection often leads to mac-
rophage activation, generation of inflammatory effectors,
mediators, and cytokines, non-specific phagocytic activ-
ity, and consequent immune-mediated injury [22].
Lymph node cellularity in a patient with HME (left) and RMSF  (right) (H&E; original magnification 64×) Figure 2
Lymph node cellularity in a patient with HME (left) and RMSF 
(right) (H&E; original magnification 64×).
Hemophagocytosis in lymph nodes from a patient with HME  (left) and RMSF (right) (H&E; original magnification 240×) Figure 1
Hemophagocytosis in lymph nodes from a patient with HME 
(left) and RMSF (right) (H&E; original magnification 240×).BMC Infectious Diseases 2006, 6:121 http://www.biomedcentral.com/1471-2334/6/121
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Hematologic data were not available for these cases,
which in general reflect the more severe end of the disease
spectrum. However, it is well recognized that patients
with HME and RMSF, especially when severe, demon-
strate leukopenia, thrombocytopenia, and anemia,
although the disease process and degree of cytopenias dif-
fer from those observed in severe acquired or hereditary
hemophagocytic syndromes [23].
The precise mechanism by which E. chaffeensis modulates
the host innate or adaptive immunity to generate such
immunologic injury is unclear. Several recent studies have
begun to shed light on ehrlichial immunopathogenesis,
with infection of human macrophage cell lines resulting
in transcriptional alterations associated with down-regu-
lated macrophage function [24], with production of dys-
functional cytotoxic TNFα by CD8 T lymphocytes [21], or
by direct stimulation of NKT cells to produce excessive
quantities of IFNγ [25].
Potential pitfalls of this study include the biased selection
of patients that represent the most severe spectrum of
HME or RMSF – fatal cases – and the relatively small
number of cases examined. Both of these situations result
from the relatively rare access to pathologically-examined
cases of both HME and RMSF, limiting the power of this
study. Similarly, the small number of infectious controls
could equally under-represent immunopathologic
responses among these entities. Despite these limitations,
the small number of cases allowed at least partial study,
Immunophenotypic changes in lymph nodes from patients with HME Figure 3
Immunophenotypic changes in lymph nodes from patients with HME. Note the marked expansion of CD8 cells in the medul-
lary and paracortical regions (a) not observed in the control lymph node from a patient with bacterial bronchopneumonia (b). 
Although not quantitatively different, CD68 macrophages were more clustered within the medullary sinuses and paracortical 
regions in lymph nodes from HME patients (c) compared with the marginal distribution observed in a control lymph node from 
a patient with bacterial bronchopneumonia (d) (Immunoperoxidase with hematoxylin counterstain; original magnifications 
20×).BMC Infectious Diseases 2006, 6:121 http://www.biomedcentral.com/1471-2334/6/121
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and provides evidence of rickettsial immunopathogenic-
ity in humans that should provide impetus for further
study in both HME and RMSF, even among mild to mod-
erately severe infections.
Conclusion
HME and RMSF are both caused by related obligate intra-
cellular bacteria, and both induce hemophagocytosis in
lymph nodes to a degree greater than a cohort of ran-
domly selected normal and infectious disease controls.
Animal models clearly show a direct role for pathogen-
induced cytotoxic injury in vivo with R. rickettsii. How-
ever, the relatively low quantities of E. chaffeensis and the
marked expansion of CD8 T cells in HME support a role
for immunopathology in vivo in humans, perhaps related
to the dysregulated proinflammatory cytokine generation
as demonstrated in animal models. Much more study will
be required to dissect the immunopathogenesis of Ehrli-
chia infections, and the studies here provide additional
evidence that infection may involve cytotoxic T cell activa-
tion and proliferation that could drive excessive macro-
phage activation as a mechanism for generating tissue-
damaging effectors in HME.
Abbreviations
HME Human monocytic ehrlichiosis
RMSF Rocky Mountain spotted fever
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